286 related articles for article (PubMed ID: 26262685)
1. Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis.
Teshima T; Matsumoto H; Okusa T; Nakamura Y; Koyama H
PLoS One; 2015; 10(8):e0135516. PubMed ID: 26262685
[TBL] [Abstract][Full Text] [Related]
2. Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.
Teshima T; Matsumoto H; Okusa T; Uchiyama R; Koyama H
PLoS One; 2016; 11(11):e0166267. PubMed ID: 27824928
[TBL] [Abstract][Full Text] [Related]
3. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
4. Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis.
Teshima T; Hara Y; Takekoshi S; Nezu Y; Harada Y; Yogo T; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):32-44. PubMed ID: 19041802
[TBL] [Abstract][Full Text] [Related]
5. Differential actions of metyrapone on the fetal pituitary-adrenal axis in the sheep fetus in late gestation.
Warnes KE; McMillen IC; Robinson JS; Coulter CL
Biol Reprod; 2004 Aug; 71(2):620-8. PubMed ID: 15265784
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 11beta-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells.
Nigawara T; Iwasaki Y; Asai M; Yoshida M; Kambayashi M; Sashinami H; Hashimoto K; Suda T
Endocrinology; 2006 Feb; 147(2):769-72. PubMed ID: 16254034
[TBL] [Abstract][Full Text] [Related]
7. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
8. Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists.
van der Pas R; Feelders RA; Gatto F; de Bruin C; Pereira AM; van Koetsveld PM; Sprij-Mooij DM; Waaijers AM; Dogan F; Schulz S; Kros JM; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1880-90. PubMed ID: 24081741
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
10. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
[TBL] [Abstract][Full Text] [Related]
11. Cortisol-secreting adrenal adenomas express 11beta-hydroxysteroid dehydrogenase type-2 gene yet possess low 11beta-HSD2 activity.
Mazzocchi G; Aragona F; Malendowicz LK; Gottardo L; Nussdorfer GG
J Investig Med; 2001 Mar; 49(2):191-4. PubMed ID: 11288760
[TBL] [Abstract][Full Text] [Related]
12. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Melmed S
Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
[TBL] [Abstract][Full Text] [Related]
14. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
Fukuoka H; Cooper O; Ben-Shlomo A; Mamelak A; Ren SG; Bruyette D; Melmed S
J Clin Invest; 2011 Dec; 121(12):4712-21. PubMed ID: 22105169
[TBL] [Abstract][Full Text] [Related]
15. Role of local 11 beta-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas.
Mune T; Morita H; Suzuki T; Takahashi Y; Isomura Y; Tanahashi T; Daido H; Yamakita N; Deguchi T; Sasano H; White PC; Yasuda K
J Clin Endocrinol Metab; 2003 Feb; 88(2):864-70. PubMed ID: 12574226
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein 4 and bone morphogenetic protein receptor expression in the pituitary gland of adult dogs in healthy condition and with ACTH-secreting pituitary adenoma.
Sato A; Ochi H; Harada Y; Yogo T; Kanno N; Hara Y
Domest Anim Endocrinol; 2017 Jan; 58():126-133. PubMed ID: 26542941
[TBL] [Abstract][Full Text] [Related]
17. Effects of maternal dexamethasone treatment in early pregnancy on pituitary-adrenal axis in fetal sheep.
Braun T; Li S; Sloboda DM; Li W; Audette MC; Moss TJ; Matthews SG; Polglase G; Nitsos I; Newnham JP; Challis JR
Endocrinology; 2009 Dec; 150(12):5466-77. PubMed ID: 19846612
[TBL] [Abstract][Full Text] [Related]
18. Plasma pro-opiomelanocortin, pro-adrenocorticotropin hormone, and pituitary adenoma size in dogs with Cushing's disease.
Granger N; de Fornel P; Devauchelle P; Segond S; Delisle F; Rosenberg D
J Vet Intern Med; 2005; 19(1):23-8. PubMed ID: 15715043
[TBL] [Abstract][Full Text] [Related]
19. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas.
Regazzo D; Mondin A; Scaroni C; Occhi G; Barbot M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742910
[TBL] [Abstract][Full Text] [Related]
20. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
